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tors focus on providing the pharmaceutical industry with a
mechanism for assessing reward for innovation. They also assess
the pattern of new listings and changes in the structure of expen-
ditures under the Australian Pharmaceutical Beneﬁts Scheme.
The study shows that the average time from marketing approval
to reimbursement is 15 months, that expenditure by government
is driven mostly by volume increase for products that have been
listed for more than 12 months and not by recent listings or price
changes, and that products are more likely to be rejected if they
are assessed on a cost-effectiveness basis (42% approved) than
on a cost-minimisation basis (88% approved). CONCLUSIONS:
This is part of an ongoing effort to develop key performance
indicators and to date has been supported by industry and 
Government. In part, this is a response to the improved levels of
transparency and cooperation engendered by the Free Trade
Agreement between Australia and the USA.
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OBJECTIVES: To explore the relationship between the length of
a General Practitioner consultation and the number of prescrip-
tions issued. Initially it is necessary to establish if any trends exist
in prescriber activity and consultation length. METHODS: The
DIN-LINK database was used to obtain data on prescriber activ-
ity. DIN-LINK is a longitudinal patient database comprising over
3.8 million electronic patient records and is populated with data
from General Practices across Great Britain. This analysis was
based on patients consulting with a GP in the year to August
2004. Data on the number of prescriptions issued in a consulta-
tion in the database were stratiﬁed by consultation length, with
1–3 minutes being the lowest consultation length band, and
21–24 minutes the highest band. A 13–15 minute band was
included as it constituted the central value of this stratiﬁcation.
The unpaired student t-test was used to test for statistical sig-
niﬁcance between groups. RESULTS: The cohort for this analy-
sis comprised 467,446 patients, of whom 45% were male. The
mean age of the cohort was 42.4 years. Over the one-year period,
the cohort had 2,425,790 consultations, during which 2,181,974
prescriptions were issued. Statistically signiﬁcant differences in
the mean number of prescriptions per consultation were found
between the lowest and central band, and the lowest and highest
band (p < 0.001). At a consultation length of 1–3 minutes, 
GPs prescribed an average of 0.6 prescriptions per consultation.
This value peaked and plateaued at 1.1 prescriptions per con-
sultation at a consultation length of 13–15 minutes. CONCLU-
SIONS: Prescribing increased as consultation length increased up
to 13–15 minutes, after which a plateau in prescriber activity
was seen. This suggests that the incremental beneﬁt of consulta-
tions over 15 minutes may be limited. Further study is planned
with quantiﬁcation of the relationship between consultation
length and prescriber activity. Regression analysis is planned for
2005.
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OBJECTIVES: To assess trends in prescriber activity related to
patient smoking status and ACORN socio-economic status. The
ﬁndings will be used to identify variables for subsequent regres-
sion analysis of the relationship between prescriber activity and
consultation length. METHODS: The DIN-LINK database was
used to obtain detailed data on prescriber activity. DIN-LINK is
a longitudinal patient database comprising over 3.8 million elec-
tronic patient records, populated with data from General Prac-
tices across Great Britain. This analysis was based on patients
consulting with a GP in the year to August 2004. Patients were
stratiﬁed by smoking status and by ACORN socio-economic
classiﬁcation (CACI Ltd., www.caci.co.uk/acorn); measures of
prescriber activity were examined, including the number of pre-
scriptions per patient/per consultation, and the number of 
consultations per patient. The unpaired student t-test was used
to test for statistical signiﬁcant differences between groups.
RESULTS: The cohort comprised 467,446 patients, of which
339,275 had a record of smoking status and 415,418 had their
ACORN socio-economic status recorded. Among the sub-group
with smoking status recorded, signiﬁcant differences were found
between current smokers, non-smokers, and ex-smokers in mean
consultations per patient, prescriptions per patient, and pre-
scriptions per consultation. Although signiﬁcant results were
found, no trends were apparent. The only non-signiﬁcant com-
parisons were in mean prescriptions per consultation between
current smokers and ex-smokers, and in mean consultations 
per patient between current smokers and non-smokers. When
considering patients’ socio-economic status, those in the lowest
group (“Hard Pressed”) consulted more frequently and were
issued signiﬁcantly more prescriptions per head and signiﬁcantly
more prescriptions per consultation compared to the highest
ACORN group (“Wealthy Achievers”). CONCLUSIONS: We
found statistically signiﬁcant differences in prescriber activity
with respect to patients’ recorded smoking and socio-economic
status. Our ﬁndings have highlighted the potential of these two
factors as suitable variables for regression analysis planned for
2005.
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OBJECTIVE: The decision to prescribe one drug instead of
another within the same therapeutic class may be inﬂuenced by
a variety of drug-related, direct, or indirect factors; but little is
known about which considerations are most important in such
choices. The low-molecular-weight heparins (LMWHs) represent
a class of drugs that are commonly used and for which thera-
peutic equivalence has been debated in the literature. The
purpose of this study was to identify and compare factors per-
ceived by physicians and clinical pharmacists to be inﬂuential in
prescribing decisions among LMWHs. METHODS: Physicians
and clinical pharmacists were interviewed to elicit information
and rank factors that inﬂuence the prescribing and use of
LMWHs in community hospitals. For each factor, the mean and
median of the rating was determined along with the frequency
distribution across ratings. The nonparametric Mann-Whitney U
test was used to examine differences between physicians and clin-
ical pharmacists. RESULTS: Both groups considered efﬁcacy,
formulary status, and policies restricting drug use to be highly
inﬂuential in the decision to use one LMWH versus another.
Compared to clinical pharmacists, physicians rated personal
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experience as more inﬂuential, whereas they rated drug cost and
prescribing guidelines lower. CONCLUSIONS: These ﬁndings
suggest that physicians and clinical pharmacists differentiate
between LMWHs based on differences between products and
because of hospital administrative programs (such as drug for-
mularies). This information may be of value in designing pro-
grams to alter medication use in community hospitals.
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OBECTIVES: Documented gaps between best practice (deter-
mined by scientiﬁc evidence) and actual patient care has led
efforts to modify physician behavior with varying, but often
modest, results. Researchers in this ﬁeld have suggested imple-
mentation of strategies based on the behavior change theory, the
Transtheoretical Model (TTM) of change. The TTM suggests
that individuals exhibit varying stages of motivational readiness
for change on a behavior and that targeting an intervention to
his/her stage of change is crucial to achieving change. The aim
of this systematic review was to examine research applications
of the TTM for explaining, predicting or guiding interventions
aimed at changing physician patient care. METHODS: One
researcher conducted a systematic search of several databases
(MEDLINE, Cochrane Database of Systematic Reviews, Inter-
national Pharmaceutical Abstracts, Social Science Abstracts,
PsycInfo, and others) using a three-tiered approach with increas-
ing speciﬁcity at each level for the period, 1995 through 2004.
Peer-reviewed manuscripts, of any study design, seeking to inﬂu-
ence, explain and/or predict physician behavior using stage of
change were included. RESULTS: Twelve studies employing at
least some TTM constructs were identiﬁed. Six used surveys to
explain physician behavior, four studies employed a TTM assess-
ment to predict the success of interventions to improve screen-
ing rates (chlamydial, colorectal cancer), and two employed
interviews or focus groups to explain physician counseling
behavior (smoking cessation and psychological counseling) and
prescribing behavior (beta blockers for myocardial infarction).
CONCLUSIONS: Stage of change constructs have been used to
explain and/or predict physician behavior, but no studies have
been reported which actually tested TTM-based interventions in
an experimental design. Because TTM-based interventions have
been successful in achieving behavior change in other target
behaviors, and since stage of change has been shown to predict
physician behavior, future research to test such interventions for
changing physician behavior towards evidence-based medicine is
warranted.
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OBJECTIVES: To determine if the use of a protocol and special
order form for the sedation of mechanically ventilated patients
reduced the incidence of adverse clinical outcomes and reduced
the cost of care of those patients. METHODS: In 2003 the 
hospital’s costs of propofol, an intravenous sedation agent had
increased by ﬁvefold over 2002. In addition, the frequency of
ventilator-associated pneumonias (“VAP”), and average duration
of time for ventilation, both increased throughout 2003. An 
evidence-based protocol was developed, requiring certain 
conditions to be met before propofol could be used, and was
implemented in January, 2004. In June, 2004, the pharmacy and
nursing departments worked together with key physicians to
ensure the protocol was being followed and appropriate selec-
tions were made from available alternatives. The length of stay
in the ICU, during of ventilation, frequency of VAP, and dollars
expended on intravenous sedation agents were compared
between three periods: 2003 (pre-protocol), the ﬁrst ﬁve-months
of 2004 (protocol in place but not enforced), and the second 
ﬁve-months of 2004, in which the protocol was enforced by
pharmacy and nursing. RESULTS: All measured parameters and
outcomes in the second ﬁve month period showed a statistically
signiﬁcant improvement over both 2003 and the ﬁrst ﬁve-months
of 2004. Compliance with the protocol improved signiﬁcantly
between the ﬁrst and second ﬁve month periods in 2004. There
was no statistical difference in outcomes between 2003 and the
ﬁrst protocol period. CONCLUSION: The use of a sedation pro-
tocol should be successful at reducing costs of propofol and
reducing the negative clinical aspects associated with mechani-
cal ventilation. The use of a protocol built on evidence based
medicine is a good ﬁrst step towards improving clinical and eco-
nomic outcomes; however, it must be accompanied by physician
education and enforcement, and a collaboration between physi-
cians, nursing, and pharmacy.
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OBJECTIVES: Anticoagulants are widely used and represent a
class of drugs that are problem-prone and have a high potential
for adverse patient outcomes. As such, these drugs may be
amenable to the use of prescribing guidelines. However, rela-
tively little has been published on the effect of such guidelines
on clinical outcomes or costs of care. The purpose of this study
was to assess whether guidelines improve the appropriateness of
prescribing, clinical outcomes, and the costs associated with 
use of anticoagulants in a sample of community hospitals in the
United States. METHODS: A retrospective analysis was per-
formed of data voluntarily collected by 15 hospitals before
(July–September 2001) and after (March–May 2002) implemen-
tation of anticoagulant prescribing guidelines. Statistical analy-
ses of both patient-level and hospital-level variables were
conducted. RESULTS: Implementation of the guidelines resulted
in a signiﬁcant increase in the proportion of anticoagulants that
were prescribed appropriately (59.8% v. 86.9%, p < 0.001). The
guidelines also resulted in a shift in the type of anticoagulants
prescribed (decreased use of unfractionated heparin and
increased use of low-molecular-weight heparins). There was sug-
gestive evidence, though not statistically signiﬁcant, that the
guidelines resulted in fewer anticoagulant-associated adverse
events (total bleeding RR = 0.71) and lower costs (savings of
$56.15 per patient per day). CONCLUSIONS: While limitations
existed with the study design, sufﬁcient beneﬁts were identiﬁed
to warrant hospitals to consider use of these or similar guide-
lines on a routine basis. Clearly, additional study in this area
would be useful.
